Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-014608
Filing Date
2021-03-22
Accepted
2021-03-22 17:06:29
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 abio-s3.htm S-3 725171
2 EX-5.1 abio-ex51_6.htm EX-5.1 38519
3 EX-23.1 abio-ex231_7.htm EX-23.1 3066
4 GRAPHIC giyymiiapsyu000001.jpg GRAPHIC 33607
5 GRAPHIC gfmbjgykfcfh000001.jpg GRAPHIC 8908
6 GRAPHIC gfmbjgykfcfh000002.jpg GRAPHIC 7119
  Complete submission text file 0001564590-21-014608.txt   836749
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-254585 | Film No.: 21762021
SIC: 2835 In Vitro & In Vivo Diagnostic Substances